Most Popular
-
1
Korea’s homegrown nanosatellite successfully launches into space
-
2
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
3
Nicaragua shuts down Seoul embassy
-
4
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
-
5
Hybe's multilabel system tested amid conflict with Ador
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
6
SNU profs to suspend treatment for one day
-
7
SK hynix pledges W20tr to ramp up DRAM production at home
-
8
Over-50s, men, single-person households take up majority of those filing for bankruptcy
-
9
Ministry denies blame for Jamboree debacle
-
10
Pianist Cho Seong-Jin named Berlin Philharmonic's artist-in-residence
[DISCLOSURE] GNCO (065060) said on Sept. 7 that it will invest 3.62 billion won (US$3.31 million) in its subsidiary Sumagen by issuing 786,654 stocks to fund its clinical investigation for AIDS vaccine development.
The amount is equivalent to 2.59 percent of the company’s equity capital.
After the acquisition on Sept. 8, GNCO’s stake in the company will rise to 35.22 percent.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
The amount is equivalent to 2.59 percent of the company’s equity capital.
After the acquisition on Sept. 8, GNCO’s stake in the company will rise to 35.22 percent.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
![[KH Explains] Korean shipbuilding stocks rally: Real growth or bubble?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/25/20240425050656_0.jpg&u=)
